Marco Alfo'

Full Professor

Sapienza University of Rome
Country flagItaly

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Marco Alfo' is a Full Professor at Sapienza Università di Roma, Italy. His research interests focus on statistical models, particularly in the areas of population estimation in capture-recapture experiments, ecological studies of lung cancer risk, and modeling node heterogeneity in multidimensional networks. His recent publications reflect a commitment to advancing statistical methodologies and their applications in public health and social sciences.

Articles (11)

Year:

2026

Year:

2026

Enhancing reproducibility and data accessibility is essential to scientific research. However, ensuring data privacy while achieving these goals is challenging, especially in the medical field, where sensitive data are often commonplace. One possible solution is to use synthetic data that mimic real-world datasets. This approach may help to streamline therapy evaluation and enable quicker access to innovative treatments. We propose using a method based on sequential conditional regressions, such as in a fully conditional specification (FCS) approach, along with flexible parametric survival models to accurately replicate covariate patterns and survival times. To make our approach available to a wide audience of users, we have developed user-friendly functions in R and Python to implement it. We also provide an example application to registry data on patients affected by Creutzfeld–Jacob disease. The results show the potentialities of the proposed method in mirroring observed multivariate distributions and survival outcomes.

Year:

2025

The COVID-19 pandemic has severely impacted Italy, leading to millions of cases and high mortality rates. Pre-existing chronic respiratory diseases may influence patient outcomes, and understanding their role is essential for improving healthcare strategies during such crises. This study analysed data from the Italian hospital discharge records database to explore the association between chronic respiratory diseases and in-hospital mortality due to COVID-19. Patients hospitalized in 2020 were studied, with exposure to respiratory diseases assessed based on hospitalizations between 2010 and 2019. Cox regression models were used to adjust for demographic and clinical factors, including age, gender, and comorbidity. Patients with pre-existing chronic respiratory diseases (n = 28 375, 13.9% of the total study population of 203 820) had a 71% higher risk (hazard ratio: 1.71, confidence interval: 1.54–1.90, P < .001) of in-hospital mortality compared to those without such conditions. Age, gender, the number of previous hospitalizations, and the Charlson comorbidity index were identified as key factors in mortality. Kaplan–Meier survival curves demonstrated significant differences in survival probabilities between exposed and unexposed groups across various age categories. Chronic respiratory diseases are associated with increased COVID-19 mortality, underscoring the need for targeted interventions in vulnerable populations to reduce the impact of future pandemics.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Context The utility of thyroglobulin (Tg) in the follow-up of patients with differentiated thyroid cancer has been well-documented. Although third-generation immunoassays have improved accuracy, limitations persist (interfering anti-Tg antibodies and measurement variability). Evolving treatment strategies require a reevaluation of Tg thresholds for optimal patient management. Objective To assess the performance of serum Tg testing in 2 populations: patients receiving total thyroidectomy and radioiodine remnant ablation (RRA) or treated with thyroidectomy alone. Design Prospective observational study. Setting Centers contributing to the Italian Thyroid Cancer Observatory database. Patients We included 540 patients with 5 years of follow-up and negative anti-Tg antibodies. Interventions Serum Tg levels assessed at 1-year follow-up visit. Main Outcome Measure Detection of structural disease within 5 years of follow-up. Results After excluding 26 patients with structural disease detected at any time point, the median Tg did not differ between patients treated with or without radioiodine. Data-driven Tg thresholds were established based on the 97th percentile of Tg levels in disease-free individuals: 1.97 ng/mL for patients undergoing thyroidectomy alone (lower than proposed by the Memorial Sloan Kettering Cancer Center protocol and ESMO Guidelines, yet demonstrating good predictive ability, with a negative predictive value of 98% and 0.84 ng/mL for patients receiving postsurgical RRA. High sensitivity and negative predictive value supported the potential of these thresholds in excluding structural disease. Conclusion This real-world study provides evidence for the continued reliability of 1-year serum Tg levels. The data-driven Tg thresholds proposed offer valuable insights for clinical decision-making in patients undergoing total thyroidectomy with or without RRA.

Year:

2024

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Maria Chiara Zatelli

Associate Professor

University of Ferrara

ITALY
View details

Alessandra Spagnoli

Sapienza University of Rome

ITALY
View details

Giorgio Grani

Associate Professor of Internal Medicine

Sapienza University of Rome

ITALY
View details

Clotilde Sparano

University of Florence

ITALY
View details

Silvia D'Angelo

Assistant Professor

Trinity College

IRELAND
View details

Elena Fabrizi

Associate Professor

Università degli Studi di Teramo

ITALY
View details